Table 1.
Characteristics of participants.
| Sample, Count | Sex (F/M) | Age Mean (SD), year |
Disease Duration Mean (SD), year |
H&Y Stage Mean (SD) | |
|---|---|---|---|---|---|
| Li et al. (2020)27 | 48 | 16/32 | 61.6 (7.6) | 6.0 (4.8) | 1.8 (0.6) |
| Chung et al. (2020)28 | 50 | 24/26 | 62.3 (6.0) | 6.5 (4.0) | 2.2 (0.3) |
| Mi et al. (2019)29 | 30 | 16/14 | 63.6 (9.9) | 8.6 (5.5) | 2.5 (0.9) |
| Khedr et al. (2019)30 | 33 | N/A | 59.5 (9.2) | 6.0 (3.8) | 3.2 (1.1) |
| Cohen et al. (2018)31 | 42 | 10/32 | 65.6 (7.5) | 5.1 (3.5) | 2.0 (0.37) |
| Buard et al. (2018)32 | 46 | 13/33 | 68.5 (7.6) | N/A | N/A |
| Yokoe et al. (2017)33 | 19 | 12/7 | 69.1 (8.4) | 9.5 (3.2) | 3.5 (0.6) |
| Brys et al. (2016)34 | 61 | 24/37 | 63.4 (10.0) | 6.9 (4.7) | 2.5 (0.6) |
| Makkos et al. (2016)35 | 44 | 20/14 | 66.5 (8.0) | 5.5 (4.8) | 2.3 (0.8) |
| Kim et al. (2015)36 | 17 | 5/12 | 64.5 (8.4) | 7.8 (4.9) | 3.0 (0.5) |
| Maruo et al. (2013)37 | 21 | 10/11 | 63.0 (11.3) | 12.0 (6.3) | 3.1 (0.5) |
| Benninger et al. (2012)38 | 26 | 6/20 | 64.1 (8.5) | 9.0 (5.5) | 2.6 (0.4) |
| Pal et al. (2010)39 | 22 | 11/11 | 68.5 (7.9) | 6.0 (4.8) / 6.5 (5)a | N/A |
| Filipović et al (2009)40 | 10 | 5/5 | 64.5 (9.6) | 15.6 (5.7) | N/A |
a
Active group/Sham group: Median (SD), SD converted from IQR, SD=IQR/1.35.
Abbreviations: SD, standard deviation; F/M, Female/Male, H&Y stage, Hohn and Yahr Scale stage.